| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| CVS - CVS Health Corp | HOLD | 0 @ USD 66.84 | USD 0 | The current share valuation price of CVS based on adjusted close was USD 66.84. The average price that CVS shares were previous bought at was USD 63.3062. The current market price is 5.6% higher than average price they were purchased at. The value of the holding in CVS has fallen by USD 148,980 compared to the previous valuation of CVS Health Corp |
| DVA - DaVita HealthCare Partners Inc | SELL | -25 @ USD 135.79 | USD -3,395 | The ETF sold 25 shares of DVA on 2025-06-18. The shares were previously bought for an average price of USD 152.269. The DaVita HealthCare Partners Inc shares were sold for -10.8% lower than average price of previous purchases. This resulted in an overall loss of USD 412 The average price that the ETF previously sold DVA share for is USD 152.628 which is higher than the selling price of USD 135.79 on 2025-06-18. |
| CRL - Creightons Plc | SELL | -28 @ USD 145.29 | USD -4,068 | The ETF sold 28 shares of CRL on 2025-06-18. The shares were previously bought for an average price of USD 166.213. The Creightons Plc shares were sold for -12.6% lower than average price of previous purchases. This resulted in an overall loss of USD 586 The average price that the ETF previously sold CRL share for is USD 185.998 which is higher than the selling price of USD 145.29 on 2025-06-18. |
| TECH - Bio-Techne Corp | SELL | -87 @ USD 50.13 | USD -4,361 | The ETF sold 87 shares of TECH on 2025-06-18. The shares were previously bought for an average price of USD 63.1863. The Bio-Techne Corp shares were sold for -20.7% lower than average price of previous purchases. This resulted in an overall loss of USD 1,136 The average price that the ETF previously sold TECH share for is USD 69.3199 which is higher than the selling price of USD 50.13 on 2025-06-18. |
| MRNA - Moderna Inc | SELL | -184 @ USD 25.4 | USD -4,674 | The ETF sold 184 shares of MRNA on 2025-06-18. The shares were previously bought for an average price of USD 34.2369. The Moderna Inc shares were sold for -25.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,626 The average price that the ETF previously sold MRNA share for is USD 40.7088 which is higher than the selling price of USD 25.4 on 2025-06-18. |
| HSIC - Henry Schein Inc | SELL | -69 @ USD 71.13 | USD -4,908 | The ETF sold 69 shares of HSIC on 2025-06-18. The shares were previously bought for an average price of USD 72.5185. The Henry Schein Inc shares were sold for -1.9% lower than average price of previous purchases. This resulted in an overall loss of USD 96 The average price that the ETF previously sold HSIC share for is USD 71.1138 so the ETF has sold 69 shares on 2025-06-18 at a higher price than the previous selling average. |
| UHS - Universal Health Services Inc | SELL | -31 @ USD 171.24 | USD -5,308 | The ETF sold 31 shares of UHS on 2025-06-18. The shares were previously bought for an average price of USD 187.055. The Universal Health Services Inc shares were sold for -8.5% lower than average price of previous purchases. This resulted in an overall loss of USD 490 The average price that the ETF previously sold UHS share for is USD 191.929 which is higher than the selling price of USD 171.24 on 2025-06-18. |
| SOLV - Solventum Corp. | SELL | -74 @ USD 72.63 | USD -5,375 | The ETF sold 74 shares of SOLV on 2025-06-18. The shares were previously bought for an average price of USD 73.9854. The Solventum Corp. shares were sold for -1.8% lower than average price of previous purchases. This resulted in an overall loss of USD 100 The average price that the ETF previously sold SOLV share for is USD 70.4983 so the ETF has sold 74 shares on 2025-06-18 at a higher price than the previous selling average. |
| VTRS - Viatris Inc | SELL | -669 @ USD 8.77 | USD -5,867 | The ETF sold 669 shares of VTRS on 2025-06-18. The shares were previously bought for an average price of USD 10.2428. The Viatris Inc shares were sold for -14.4% lower than average price of previous purchases. This resulted in an overall loss of USD 985 The average price that the ETF previously sold VTRS share for is USD 11.9246 which is higher than the selling price of USD 8.77 on 2025-06-18. |
| INCY - Incyte Corporation | SELL | -89 @ USD 68.27 | USD -6,076 | The ETF sold 89 shares of INCY on 2025-06-18. The shares were previously bought for an average price of USD 68.9882. The Incyte Corporation shares were sold for -1.0% lower than average price of previous purchases. This resulted in an overall loss of USD 64 The average price that the ETF previously sold INCY share for is USD 72.1907 which is higher than the selling price of USD 68.27 on 2025-06-18. |
| RVTY - Revvity Inc. | SELL | -68 @ USD 94.41 | USD -6,420 | The ETF sold 68 shares of RVTY on 2025-06-18. The shares were previously bought for an average price of USD 110.222. The Revvity Inc. shares were sold for -14.3% lower than average price of previous purchases. This resulted in an overall loss of USD 1,075 The average price that the ETF previously sold RVTY share for is USD 112.638 which is higher than the selling price of USD 94.41 on 2025-06-18. |
| ALGN - Align Technology Inc | SELL | -39 @ USD 180.01 | USD -7,020 | The ETF sold 39 shares of ALGN on 2025-06-18. The shares were previously bought for an average price of USD 187.013. The Align Technology Inc shares were sold for -3.7% lower than average price of previous purchases. This resulted in an overall loss of USD 273 The average price that the ETF previously sold ALGN share for is USD 213.008 which is higher than the selling price of USD 180.01 on 2025-06-18. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -112 @ USD 69.81 | USD -7,819 | The ETF sold 112 shares of COO on 2025-06-18. The shares were previously bought for an average price of USD 87.0974. The The Cooper Companies, Inc. Common Stock shares were sold for -19.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,936 The average price that the ETF previously sold COO share for is USD 94.6545 which is higher than the selling price of USD 69.81 on 2025-06-18. |
| HOLX - Hologic Inc | SELL | -124 @ USD 63.97 | USD -7,932 | The ETF sold 124 shares of HOLX on 2025-06-18. The shares were previously bought for an average price of USD 66.6156. The Hologic Inc shares were sold for -4.0% lower than average price of previous purchases. This resulted in an overall loss of USD 328 The average price that the ETF previously sold HOLX share for is USD 71.6242 which is higher than the selling price of USD 63.97 on 2025-06-18. |
| BAX - Baxter International Inc | SELL | -280 @ USD 29.8 | USD -8,344 | The ETF sold 280 shares of BAX on 2025-06-18. The shares were previously bought for an average price of USD 32.922. The Baxter International Inc shares were sold for -9.5% lower than average price of previous purchases. This resulted in an overall loss of USD 874 The average price that the ETF previously sold BAX share for is USD 32.3409 which is higher than the selling price of USD 29.8 on 2025-06-18. |
| WST - West Pharmaceutical Services Inc | SELL | -39 @ USD 217.95 | USD -8,500 | The ETF sold 39 shares of WST on 2025-06-18. The shares were previously bought for an average price of USD 251.845. The West Pharmaceutical Services Inc shares were sold for -13.5% lower than average price of previous purchases. This resulted in an overall loss of USD 1,322 The average price that the ETF previously sold WST share for is USD 299 which is higher than the selling price of USD 217.95 on 2025-06-18. |
| MOH - MOH | SELL | -30 @ USD 295.34 | USD -8,860 | The ETF sold 30 shares of MOH on 2025-06-18. The shares were previously bought for an average price of USD 307.39. The MOH shares were sold for -3.9% lower than average price of previous purchases. This resulted in an overall loss of USD 362 The average price that the ETF previously sold MOH share for is USD 306.425 which is higher than the selling price of USD 295.34 on 2025-06-18. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -30 @ USD 295.34 | USD -8,860 | The ETF sold 30 shares of MOH on 2025-06-18. The shares were previously bought for an average price of USD 307.39. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for -3.9% lower than average price of previous purchases. This resulted in an overall loss of USD 362 The average price that the ETF previously sold MOH share for is USD 306.425 which is higher than the selling price of USD 295.34 on 2025-06-18. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -109 @ USD 90.55 | USD -9,870 | The ETF sold 109 shares of ZBH on 2025-06-18. The shares were previously bought for an average price of USD 105.123. The Zimmer Biomet Holdings Inc shares were sold for -13.9% lower than average price of previous purchases. This resulted in an overall loss of USD 1,588 The average price that the ETF previously sold ZBH share for is USD 106.532 which is higher than the selling price of USD 90.55 on 2025-06-18. |
| BIIB - Biogen Inc | SELL | -80 @ USD 126.54 | USD -10,123 | The ETF sold 80 shares of BIIB on 2025-06-18. The shares were previously bought for an average price of USD 143.398. The Biogen Inc shares were sold for -11.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,349 The average price that the ETF previously sold BIIB share for is USD 155.976 which is higher than the selling price of USD 126.54 on 2025-06-18. |
| WAT - Waters Corporation | SELL | -32 @ USD 339.36 | USD -10,860 | The ETF sold 32 shares of WAT on 2025-06-18. The shares were previously bought for an average price of USD 365.98. The Waters Corporation shares were sold for -7.3% lower than average price of previous purchases. This resulted in an overall loss of USD 852 The average price that the ETF previously sold WAT share for is USD 370.903 which is higher than the selling price of USD 339.36 on 2025-06-18. |
| WAT - MULETFWATIMETFP | SELL | -32 @ USD 339.36 | USD -10,860 | The ETF sold 32 shares of WAT on 2025-06-18. The shares were previously bought for an average price of USD 365.98. The MULETFWATIMETFP shares were sold for -7.3% lower than average price of previous purchases. This resulted in an overall loss of USD 852 The average price that the ETF previously sold WAT share for is USD 370.903 which is higher than the selling price of USD 339.36 on 2025-06-18. |
| DGX - Quest Diagnostics Incorporated | SELL | -62 @ USD 179.78 | USD -11,146 | The ETF sold 62 shares of DGX on 2025-06-18. The shares were previously bought for an average price of USD 168.271. The Quest Diagnostics Incorporated shares were sold for 6.8% higher than average price of previous purchases. This sale made a profit of USD 714 The average price that the ETF previously sold DGX share for is USD 160.691 so the ETF has sold 62 shares on 2025-06-18 at a higher price than the previous selling average. |
| PODD - Insulet Corporation | SELL | -38 @ USD 301.79 | USD -11,468 | The ETF sold 38 shares of PODD on 2025-06-18. The shares were previously bought for an average price of USD 272.402. The Insulet Corporation shares were sold for 10.8% higher than average price of previous purchases. This sale made a profit of USD 1,117 The average price that the ETF previously sold PODD share for is USD 265.771 so the ETF has sold 38 shares on 2025-06-18 at a higher price than the previous selling average. |
| LH - Laboratory Corporation of America Holdings | SELL | -45 @ USD 261.39 | USD -11,763 | The ETF sold 45 shares of LH on 2025-06-18. The shares were previously bought for an average price of USD 243.401. The Laboratory Corporation of America Holdings shares were sold for 7.4% higher than average price of previous purchases. This sale made a profit of USD 810 The average price that the ETF previously sold LH share for is USD 237.182 so the ETF has sold 45 shares on 2025-06-18 at a higher price than the previous selling average. |
| MTD - Mettler-Toledo International Inc | SELL | -11 @ USD 1145.47 | USD -12,600 | The ETF sold 11 shares of MTD on 2025-06-18. The shares were previously bought for an average price of USD 1229.04. The Mettler-Toledo International Inc shares were sold for -6.8% lower than average price of previous purchases. This resulted in an overall loss of USD 919 The average price that the ETF previously sold MTD share for is USD 1235.12 which is higher than the selling price of USD 1145.47 on 2025-06-18. |
| MTD - AMUNDI EUR GOV 710 | SELL | -11 @ USD 1145.47 | USD -12,600 | The ETF sold 11 shares of MTD on 2025-06-18. The shares were previously bought for an average price of USD 1229.04. The AMUNDI EUR GOV 710 shares were sold for -6.8% lower than average price of previous purchases. This resulted in an overall loss of USD 919 The average price that the ETF previously sold MTD share for is USD 1235.12 which is higher than the selling price of USD 1145.47 on 2025-06-18. |
| STE - STERIS plc | SELL | -55 @ USD 236.23 | USD -12,993 | The ETF sold 55 shares of STE on 2025-06-18. The shares were previously bought for an average price of USD 223.709. The STERIS plc shares were sold for 5.6% higher than average price of previous purchases. This sale made a profit of USD 689 The average price that the ETF previously sold STE share for is USD 217.227 so the ETF has sold 55 shares on 2025-06-18 at a higher price than the previous selling average. |
| IQV - IQVIA Holdings Inc | SELL | -92 @ USD 154.61 | USD -14,224 | The ETF sold 92 shares of IQV on 2025-06-18. The shares were previously bought for an average price of USD 186.975. The IQVIA Holdings Inc shares were sold for -17.3% lower than average price of previous purchases. This resulted in an overall loss of USD 2,978 The average price that the ETF previously sold IQV share for is USD 194.57 which is higher than the selling price of USD 154.61 on 2025-06-18. |
| CNC - Concurrent Technologies Plc | SELL | -276 @ USD 55.15 | USD -15,221 | The ETF sold 276 shares of CNC on 2025-06-18. The shares were previously bought for an average price of USD 59.5126. The Concurrent Technologies Plc shares were sold for -7.3% lower than average price of previous purchases. This resulted in an overall loss of USD 1,204 The average price that the ETF previously sold CNC share for is USD 59.9225 which is higher than the selling price of USD 55.15 on 2025-06-18. |
| HUM - Hummingbird Resources PLC | SELL | -66 @ USD 243.4 | USD -16,064 | The ETF sold 66 shares of HUM on 2025-06-18. The shares were previously bought for an average price of USD 266.685. The Hummingbird Resources PLC shares were sold for -8.7% lower than average price of previous purchases. This resulted in an overall loss of USD 1,537 The average price that the ETF previously sold HUM share for is USD 274.54 which is higher than the selling price of USD 243.4 on 2025-06-18. |
| HUM - Humana Inc | SELL | -66 @ USD 243.4 | USD -16,064 | The ETF sold 66 shares of HUM on 2025-06-18. The shares were previously bought for an average price of USD 266.685. The Humana Inc shares were sold for -8.7% lower than average price of previous purchases. This resulted in an overall loss of USD 1,537 The average price that the ETF previously sold HUM share for is USD 274.54 which is higher than the selling price of USD 243.4 on 2025-06-18. |
| DXCM - DexCom Inc | SELL | -217 @ USD 81.01 | USD -17,579 | The ETF sold 217 shares of DXCM on 2025-06-18. The shares were previously bought for an average price of USD 78.2993. The DexCom Inc shares were sold for 3.5% higher than average price of previous purchases. This sale made a profit of USD 588 The average price that the ETF previously sold DXCM share for is USD 76.1363 so the ETF has sold 217 shares on 2025-06-18 at a higher price than the previous selling average. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -251 @ USD 71.89 | USD -18,044 | The ETF sold 251 shares of GEHC on 2025-06-18. The shares were previously bought for an average price of USD 83.2716. The GE HealthCare Technologies Inc. shares were sold for -13.7% lower than average price of previous purchases. This resulted in an overall loss of USD 2,857 The average price that the ETF previously sold GEHC share for is USD 80.6233 which is higher than the selling price of USD 71.89 on 2025-06-18. |
| A - Agilent Technologies Inc | SELL | -157 @ USD 115.52 | USD -18,137 | The ETF sold 157 shares of A on 2025-06-18. The shares were previously bought for an average price of USD 127.409. The Agilent Technologies Inc shares were sold for -9.3% lower than average price of previous purchases. This resulted in an overall loss of USD 1,867 The average price that the ETF previously sold A share for is USD 131.515 which is higher than the selling price of USD 115.52 on 2025-06-18. |
| RMD - ResMed Inc | SELL | -81 @ USD 250.88 | USD -20,321 | The ETF sold 81 shares of RMD on 2025-06-18. The shares were previously bought for an average price of USD 236.002. The ResMed Inc shares were sold for 6.3% higher than average price of previous purchases. This sale made a profit of USD 1,205 The average price that the ETF previously sold RMD share for is USD 240.666 so the ETF has sold 81 shares on 2025-06-18 at a higher price than the previous selling average. |
| CAH - Cardinal Health Inc | SELL | -134 @ USD 165.4 | USD -22,164 | The ETF sold 134 shares of CAH on 2025-06-18. The shares were previously bought for an average price of USD 132.231. The Cardinal Health Inc shares were sold for 25.1% higher than average price of previous purchases. This sale made a profit of USD 4,445 The average price that the ETF previously sold CAH share for is USD 124.515 so the ETF has sold 134 shares on 2025-06-18 at a higher price than the previous selling average. |
| IDXX - IDEXX Laboratories Inc | SELL | -44 @ USD 519.85 | USD -22,873 | The ETF sold 44 shares of IDXX on 2025-06-18. The shares were previously bought for an average price of USD 450.097. The IDEXX Laboratories Inc shares were sold for 15.5% higher than average price of previous purchases. This sale made a profit of USD 3,069 The average price that the ETF previously sold IDXX share for is USD 433.235 so the ETF has sold 44 shares on 2025-06-18 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -326 @ USD 73.98 | USD -24,117 | The ETF sold 326 shares of EW on 2025-06-18. The shares were previously bought for an average price of USD 71.4954. The Edwards Lifesciences Corp shares were sold for 3.5% higher than average price of previous purchases. This sale made a profit of USD 810 The average price that the ETF previously sold EW share for is USD 70.6825 so the ETF has sold 326 shares on 2025-06-18 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -159 @ USD 168.59 | USD -26,806 | The ETF sold 159 shares of BDX on 2025-06-18. The shares were previously bought for an average price of USD 219.954. The Becton Dickinson and Company shares were sold for -23.4% lower than average price of previous purchases. This resulted in an overall loss of USD 8,167 The average price that the ETF previously sold BDX share for is USD 220.374 which is higher than the selling price of USD 168.59 on 2025-06-18. |
| COR - Cencora Inc. | SELL | -95 @ USD 296.75 | USD -28,191 | The ETF sold 95 shares of COR on 2025-06-18. The shares were previously bought for an average price of USD 259.48. The Cencora Inc. shares were sold for 14.4% higher than average price of previous purchases. This sale made a profit of USD 3,541 The average price that the ETF previously sold COR share for is USD 248.917 so the ETF has sold 95 shares on 2025-06-18 at a higher price than the previous selling average. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -58 @ USD 513.58 | USD -29,788 | The ETF sold 58 shares of REGN on 2025-06-18. The shares were previously bought for an average price of USD 682.472. The Regeneron Pharmaceuticals Inc shares were sold for -24.7% lower than average price of previous purchases. This resulted in an overall loss of USD 9,796 The average price that the ETF previously sold REGN share for is USD 736.31 which is higher than the selling price of USD 513.58 on 2025-06-18. |
| HCA - HCA Holdings Inc | SELL | -98 @ USD 376.86 | USD -36,932 | The ETF sold 98 shares of HCA on 2025-06-18. The shares were previously bought for an average price of USD 342.239. The HCA Holdings Inc shares were sold for 10.1% higher than average price of previous purchases. This sale made a profit of USD 3,393 The average price that the ETF previously sold HCA share for is USD 329.82 so the ETF has sold 98 shares on 2025-06-18 at a higher price than the previous selling average. |
| ZTS - Zoetis Inc | SELL | -247 @ USD 155.06 | USD -38,300 | The ETF sold 247 shares of ZTS on 2025-06-18. The shares were previously bought for an average price of USD 166.531. The Zoetis Inc shares were sold for -6.9% lower than average price of previous purchases. This resulted in an overall loss of USD 2,833 The average price that the ETF previously sold ZTS share for is USD 171.112 which is higher than the selling price of USD 155.06 on 2025-06-18. |
| CI - Cigna Corp | SELL | -151 @ USD 314.4 | USD -47,474 | The ETF sold 151 shares of CI on 2025-06-18. The shares were previously bought for an average price of USD 316.233. The Cigna Corp shares were sold for -0.6% lower than average price of previous purchases. This resulted in an overall loss of USD 277 The average price that the ETF previously sold CI share for is USD 312.902 so the ETF has sold 151 shares on 2025-06-18 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -127 @ USD 375.91 | USD -47,741 | The ETF sold 127 shares of ELV on 2025-06-18. The shares were previously bought for an average price of USD 406.476. The Elevance Health Inc shares were sold for -7.5% lower than average price of previous purchases. This resulted in an overall loss of USD 3,882 The average price that the ETF previously sold ELV share for is USD 401.175 which is higher than the selling price of USD 375.91 on 2025-06-18. |
| ELV - Elevance Health Inc | SELL | -127 @ USD 375.91 | USD -47,741 | The ETF sold 127 shares of ELV on 2025-06-18. The shares were previously bought for an average price of USD 406.476. The Elevance Health Inc shares were sold for -7.5% lower than average price of previous purchases. This resulted in an overall loss of USD 3,882 The average price that the ETF previously sold ELV share for is USD 401.175 which is higher than the selling price of USD 375.91 on 2025-06-18. |
| MCK - McKesson Corporation | SELL | -69 @ USD 728.91 | USD -50,295 | The ETF sold 69 shares of MCK on 2025-06-18. The shares were previously bought for an average price of USD 634.538. The McKesson Corporation shares were sold for 14.9% higher than average price of previous purchases. This sale made a profit of USD 6,512 The average price that the ETF previously sold MCK share for is USD 608.754 so the ETF has sold 69 shares on 2025-06-18 at a higher price than the previous selling average. |
| BMY - Bloomsbury Publishing Plc | SELL | -1,123 @ USD 46.84 | USD -52,601 | The ETF sold 1123 shares of BMY on 2025-06-18. The shares were previously bought for an average price of USD 56.1587. The Bloomsbury Publishing Plc shares were sold for -16.6% lower than average price of previous purchases. This resulted in an overall loss of USD 10,465 The average price that the ETF previously sold BMY share for is USD 55.967 which is higher than the selling price of USD 46.84 on 2025-06-18. |
| MDT - Medtronic PLC | SELL | -709 @ USD 85.73 | USD -60,783 | The ETF sold 709 shares of MDT on 2025-06-18. The shares were previously bought for an average price of USD 88.4502. The Medtronic PLC shares were sold for -3.1% lower than average price of previous purchases. This resulted in an overall loss of USD 1,929 The average price that the ETF previously sold MDT share for is USD 85.4858 so the ETF has sold 709 shares on 2025-06-18 at a higher price than the previous selling average. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -141 @ USD 448.4 | USD -63,224 | The ETF sold 141 shares of VRTX on 2025-06-18. The shares were previously bought for an average price of USD 474.32. The Vertex Pharmaceuticals Inc shares were sold for -5.5% lower than average price of previous purchases. This resulted in an overall loss of USD 3,655 The average price that the ETF previously sold VRTX share for is USD 462.639 which is higher than the selling price of USD 448.4 on 2025-06-18. |
| DHR - Danaher Corporation | SELL | -353 @ USD 194.44 | USD -68,637 | The ETF sold 353 shares of DHR on 2025-06-18. The shares were previously bought for an average price of USD 214.206. The Danaher Corporation shares were sold for -9.2% lower than average price of previous purchases. This resulted in an overall loss of USD 6,977 The average price that the ETF previously sold DHR share for is USD 229.173 which is higher than the selling price of USD 194.44 on 2025-06-18. |
| DHR - Danaher Corporation | SELL | -353 @ USD 194.44 | USD -68,637 | The ETF sold 353 shares of DHR on 2025-06-18. The shares were previously bought for an average price of USD 214.206. The Danaher Corporation shares were sold for -9.2% lower than average price of previous purchases. This resulted in an overall loss of USD 6,977 The average price that the ETF previously sold DHR share for is USD 229.173 which is higher than the selling price of USD 194.44 on 2025-06-18. |
| SYK - Stryker Corporation | SELL | -189 @ USD 373.26 | USD -70,546 | The ETF sold 189 shares of SYK on 2025-06-18. The shares were previously bought for an average price of USD 379.004. The Stryker Corporation shares were sold for -1.5% lower than average price of previous purchases. This resulted in an overall loss of USD 1,086 The average price that the ETF previously sold SYK share for is USD 375.448 which is higher than the selling price of USD 373.26 on 2025-06-18. |
| GILD - Guild Esports Plc | SELL | -689 @ USD 108 | USD -74,412 | The ETF sold 689 shares of GILD on 2025-06-18. The shares were previously bought for an average price of USD 103.568. The Guild Esports Plc shares were sold for 4.3% higher than average price of previous purchases. This sale made a profit of USD 3,054 The average price that the ETF previously sold GILD share for is USD 95.4036 so the ETF has sold 689 shares on 2025-06-18 at a higher price than the previous selling average. |
| PFE - Pfizer Inc | SELL | -3,134 @ USD 23.88 | USD -74,840 | The ETF sold 3134 shares of PFE on 2025-06-18. The shares were previously bought for an average price of USD 25.5985. The Pfizer Inc shares were sold for -6.7% lower than average price of previous purchases. This resulted in an overall loss of USD 5,386 The average price that the ETF previously sold PFE share for is USD 25.7945 which is higher than the selling price of USD 23.88 on 2025-06-18. |
| BSX - Boston Scientific Corporation | SELL | -814 @ USD 101.37 | USD -82,515 | The ETF sold 814 shares of BSX on 2025-06-18. The shares were previously bought for an average price of USD 99.0356. The Boston Scientific Corporation shares were sold for 2.4% higher than average price of previous purchases. This sale made a profit of USD 1,900 The average price that the ETF previously sold BSX share for is USD 91.2395 so the ETF has sold 814 shares on 2025-06-18 at a higher price than the previous selling average. |
| BSX - MULSTRXSSXIMETFP | SELL | -814 @ USD 101.37 | USD -82,515 | The ETF sold 814 shares of BSX on 2025-06-18. The shares were previously bought for an average price of USD 99.0356. The MULSTRXSSXIMETFP shares were sold for 2.4% higher than average price of previous purchases. This sale made a profit of USD 1,900 The average price that the ETF previously sold BSX share for is USD 91.2395 so the ETF has sold 814 shares on 2025-06-18 at a higher price than the previous selling average. |
| TMO - Time Out Group plc | SELL | -211 @ USD 392.56 | USD -82,830 | The ETF sold 211 shares of TMO on 2025-06-18. The shares were previously bought for an average price of USD 506.615. The Time Out Group plc shares were sold for -22.5% lower than average price of previous purchases. This resulted in an overall loss of USD 24,066 The average price that the ETF previously sold TMO share for is USD 514.359 which is higher than the selling price of USD 392.56 on 2025-06-18. |
| AMGN - Amgen Inc | SELL | -296 @ USD 289.63 | USD -85,730 | The ETF sold 296 shares of AMGN on 2025-06-18. The shares were previously bought for an average price of USD 301.699. The Amgen Inc shares were sold for -4.0% lower than average price of previous purchases. This resulted in an overall loss of USD 3,572 The average price that the ETF previously sold AMGN share for is USD 288.956 so the ETF has sold 296 shares on 2025-06-18 at a higher price than the previous selling average. |
| ISRG - Intuitive Surgical Inc | SELL | -196 @ USD 509.49 | USD -99,860 | The ETF sold 196 shares of ISRG on 2025-06-18. The shares were previously bought for an average price of USD 537.804. The Intuitive Surgical Inc shares were sold for -5.3% lower than average price of previous purchases. This resulted in an overall loss of USD 5,550 The average price that the ETF previously sold ISRG share for is USD 530.958 which is higher than the selling price of USD 509.49 on 2025-06-18. |
| MRK - Marks Electrical Group PLC | SELL | -1,399 @ USD 79.29 | USD -110,927 | The ETF sold 1399 shares of MRK on 2025-06-18. The shares were previously bought for an average price of USD 90.3054. The Marks Electrical Group PLC shares were sold for -12.2% lower than average price of previous purchases. This resulted in an overall loss of USD 15,411 The average price that the ETF previously sold MRK share for is USD 97.3178 which is higher than the selling price of USD 79.29 on 2025-06-18. |
| MRK - Merck & Company Inc | SELL | -1,399 @ USD 79.29 | USD -110,927 | The ETF sold 1399 shares of MRK on 2025-06-18. The shares were previously bought for an average price of USD 90.3054. The Merck & Company Inc shares were sold for -12.2% lower than average price of previous purchases. This resulted in an overall loss of USD 15,411 The average price that the ETF previously sold MRK share for is USD 97.3178 which is higher than the selling price of USD 79.29 on 2025-06-18. |
| ABT - Abbott Laboratories | SELL | -959 @ USD 132.41 | USD -126,981 | The ETF sold 959 shares of ABT on 2025-06-18. The shares were previously bought for an average price of USD 127.638. The Abbott Laboratories shares were sold for 3.7% higher than average price of previous purchases. This sale made a profit of USD 4,576 The average price that the ETF previously sold ABT share for is USD 118.845 so the ETF has sold 959 shares on 2025-06-18 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -507 @ USD 307.2 | USD -155,750 | The ETF sold 507 shares of UNH on 2025-06-18. The shares were previously bought for an average price of USD 499.401. The UnitedHealth Group Incorporated shares were sold for -38.5% lower than average price of previous purchases. This resulted in an overall loss of USD 97,446 The average price that the ETF previously sold UNH share for is USD 540.141 which is higher than the selling price of USD 307.2 on 2025-06-18. |
| ABBV - AbbVie Inc | SELL | -972 @ USD 185.49 | USD -180,296 | The ETF sold 972 shares of ABBV on 2025-06-18. The shares were previously bought for an average price of USD 192.622. The AbbVie Inc shares were sold for -3.7% lower than average price of previous purchases. This resulted in an overall loss of USD 6,932 The average price that the ETF previously sold ABBV share for is USD 185.253 so the ETF has sold 972 shares on 2025-06-18 at a higher price than the previous selling average. |
| JNJ - Johnson & Johnson | SELL | -1,323 @ USD 150.73 | USD -199,416 | The ETF sold 1323 shares of JNJ on 2025-06-18. The shares were previously bought for an average price of USD 157.337. The Johnson & Johnson shares were sold for -4.2% lower than average price of previous purchases. This resulted in an overall loss of USD 8,741 The average price that the ETF previously sold JNJ share for is USD 152.729 which is higher than the selling price of USD 150.73 on 2025-06-18. |
| LLY - Eli Lilly and Company | SELL | -430 @ USD 785.03 | USD -337,563 | The ETF sold 430 shares of LLY on 2025-06-18. The shares were previously bought for an average price of USD 832.356. The Eli Lilly and Company shares were sold for -5.7% lower than average price of previous purchases. This resulted in an overall loss of USD 20,350 The average price that the ETF previously sold LLY share for is USD 793.374 which is higher than the selling price of USD 785.03 on 2025-06-18. |